Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Parabilis Medicines, Inc. | 0 | 4,166,666 | +4,166,666 | $0 | $114.04M | 64.35% | +$114.04M |
| Intellia Therapeutics, Inc.(NTLA) | 3,702,995 | 3,702,995 | 0 | $47.47M | $62.65M | 35.35% | +$15.18M |
| Adicet Bio, Inc. | 0 | 60,511 | +60,511 | $0 | $522.8K | 0.30% | +$522.8K |
| Adicet Bio, Inc. | 60,511 | 0 | -60,511 | $412.1K | $0 | — | -$412.1K |